Hong Kong
· Delayed Price · Currency is HKD China Medical System Holdings Company Description
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis.
The company also offers Salofalk for treating Ulcerative Colitis and Crohn’s disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; ILUMETRI, a tildrakizumab injection to treat moderate-tosevere plaque psoriasis; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar.
In addition, it provides Aethoxysklerol for sclerotherapy of different varicose veins; Heling Soothing product for skin soothing; Vmonalisa for mid to deep dermal implantation; Neauvia Hyaluronic Acid series; EyeOP1 to treat glaucoma; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; MOVICOL for treating chronic constipation and faecal impaction; and MeteoSpasmyl to treat gastrointestinal flatulence and pain.
The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.
| Country | Cayman Islands |
| Founded | 1995 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,701 |
| CEO | Kong Lam |
Contact Details
Address: Island Place Tower North Point Hong Kong | |
| Phone | 852 2369 7678 |
| Website | web.cms.net.cn |
Stock Details
| Ticker Symbol | 0867 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG211081248 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Kong Lam | Founder, Chairman, Chief Executive Officer and President |
| Yanling Chen | Chief Financial Officer, Vice President and Executive Director |
| Hongbing Chen | Chief Operating Officer, Vice President, Director of Sales and Marketing and Executive Director |
| Sanyan Wu | Director of Legal Department and Company Secretary |
| Dr. Huaizheng Peng M.D., Ph.D. | Chief Business Officer |
| Fei Jiang | Chief Investment Officer of Greater China |
| James Patrick Stearns | Chief Investment Officer of Europe and America |